Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pulmonary masses: contrast enhancement.

J T Littleton1, M L Durizch, G Moeller

  • 1Department of Radiology, University of South Alabama Medical Center, Mobile 36617.

Radiology
|December 1, 1990
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Neurotoxicity Pathways in Drosophila Models of the Polyglutamine Disorders.

Current topics in developmental biology·2017
Same author

Atypical angina pectoris; mechanism, importance and differential diagnosis.

Guthrie Clinic bulletin·2010
Same author

A common FADS2 promoter polymorphism increases promoter activity and facilitates binding of transcription factor ELK1.

Journal of lipid research·2009
Same author

Bioinformatic identification and characterization of new members of short-chain dehydrogenase/reductase superfamily.

Molecular and cellular endocrinology·2006
Same author

Interspecies comparison of gene structure and computational analysis of gene regulation of 17beta-hydroxysteroid dehydrogenase type 1.

Molecular and cellular endocrinology·2005
Same author

Androgen metabolism via 17beta-hydroxysteroid dehydrogenase type 3 in mammalian and non-mammalian vertebrates: comparison of the human and the zebrafish enzyme.

Journal of molecular endocrinology·2005

Contrast enhancement of pulmonary masses using iodinated contrast medium shows differences between benign and malignant tumors. This method may aid in lung cancer detection, with computed tomography (CT) being explored for simplification.

Area of Science:

  • Radiology
  • Oncology
  • Medical Imaging

Background:

  • Distinguishing benign from malignant pulmonary masses is crucial in lung cancer diagnosis.
  • Previous methods relied on morphologic and computed tomographic (CT) attenuation characteristics.
  • Evaluating enhancement properties of lung masses using contrast media offers new diagnostic insights.

Purpose of the Study:

  • To review the use of intravenously administered iodinated contrast medium for assessing lung mass enhancement.
  • To identify distinctive differences in vascularity, pathophysiology, and pharmacodynamics between malignant and benign pulmonary masses.
  • To explore contrast enhancement measurement as a feasible diagnostic method for lung cancer detection.

Main Methods:

  • Review of experience with intravenously administered iodinated contrast medium in 45 patients with peripheral pulmonary masses.

Related Experiment Videos

  • Evaluation of enhancement using optical density values measured on trispiral tomograms before and after contrast injection.
  • Exploration of computed tomography (CT) as a simplified technique for enhancement measurement.

    • Main Results:

    • Distinctive differences in enhancement properties were identified between malignant and benign pulmonary masses.
    • Contrast enhancement of pulmonary masses can be quantitatively measured on sectional images.
    • The findings suggest potential for this method in lung cancer detection.

    Conclusions:

    • Contrast enhancement measurement shows promise as a diagnostic tool for differentiating pulmonary masses.
    • This technique may improve the accuracy of lung cancer detection.
    • Computed tomography (CT) is being investigated to simplify the measurement of contrast enhancement in pulmonary masses.